A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity

The alpha-synuclein mutation E83Q, the first in the NAC domain of the protein, was recently identified in a patient with dementia with Lewy bodies. We investigated the effects of this mutation on the aggregation of aSyn monomers and the structure, morphology, dynamic, and seeding activity of the aSyn fibrils in neurons. We found that it markedly accelerates aSyn fibrillization and results in the formation of fibrils with distinct structural and dynamic properties. In cells, this mutation is associated with higher levels of aSyn, accumulation of p5129, and increased toxicity. In a neuronal seeding model of Lewy body (LB) formation, the E83Q mutation significantly enhances the internalization of fibrils into neurons, induces higher seeding activity, and results in the formation of diverse aSyn pathologies, including the formation of LB-like inclusions that recapitulate the immunohisto-chemical and morphological features of brainstem LBs observed in brains of patients with Parkinson's disease.

Automated summary

The E83Q mutation in alpha-synuclein accelerates fibrillization and leads to the formation of fibrils with distinct structural and dynamic properties. In cells, this mutation is associated with increased levels of aSyn, accumulation of p5129, and higher toxicity. In a neuronal seeding model, the E83Q mutation enhances fibril internalization, induces higher seeding activity, and results in the formation of diverse aSyn pathologies.